Advancements in IVD

Nihon Kohden India is a leader in the hematology segment and installed more than 4,000 equipment across India

Specials, News

In IVD, technology is increasingly playing a role in almost all processes, patient testing to report delivering, says Nitin Srivastava, National Sales Manager-IVD, Nihon Kohden India

How has the company expanded its product portfolio over the years?
Nihon Kohden India is a leader in the hematology segment and installed more than 4,000 equipment across India by strong sales team deployed in every metro and tier 2 cities, covering B2B &C2C , targeting and positioning new products as per customer requirement.
Already we are having different types of models of hematology equipment and recently added in our product portfolio, Serum protein Analyzer Model CHM 4100 and Autoloader Hematology Analyzer with 33 parameters Model MEK 9100 has been launched.

What has been the contribution of the company towards the technological advancements in healthcare?
The reach of technological innovation continues to grow, changing all industries as it evolves. In IVD, technology is increasingly playing a role in almost all processes, patient testing to report delivering.
Nihon Kohden has upgraded their equipment technological as per demand of tropical reason, robust technology, less maintenance (micro interior installation base) affordable patient testing with quality products.

What is the USP of the company?
The USP of Nihon Kohden-IVD is ‘world class quality product with affordable cost to the patient’.

What are the products that you have for home healthcare, an emerging focus area in healthcare?
Nihon Kohden India –IVD is having Hematology Cell Counters and Serum protein analysers which are used by medical professionals at their pathology laboratories only. There is no product which is related to home care by NKI-IVD.

Which are the segments that the company enjoys the numero uno position and what are plans to consolidate that position further?
Nihon Kohden India-IVD retained its number one position of the top three players amongst 3 PDA Hematology Cell Counter for the seventh straight year, but there have been widespread changes in the pecking order beneath it.
Nihon Kohden India now has two models of 3 PDA in the top five, and two model in 5 PDA in the top five bestselling Hematology Cell counters in 2017-18 in the Indian IVD industry. Our plan to consolidate and maintain the position further is to first and foremost providing world class proven quality product with affordable prices to patients. Especially, tier 2 and tier 3 cities will be focused more.

What is in the pipeline from the company?
Presently, we have different models of hematology
cell counters, serum protein analyser and fully auto
biochemistry analyser. In the pipeline, we have more products in immunochemistry, critical care and coagulations.

Share